Explore DOJLife.com

One Comment

  1. Great article! The challenge we face is that research into preventatives and cures is largely limited to that which big pharma will fund. In addition, if their is no money in a treatment, not only will little research take place, but any such research is disparaged by big pharma experts whom want their solution to win. R&D is not cheap and the profit potential is very high. I am grateful to big pharma for many innovations, but we must keep their motivation in mind. While it is likely that supplements or drugs with expired patents or even a more nutritious diet may be all we need to end this spread without mask and distancing, we can not expect that to be promoted. Regardless of how, we know HaShem will make inexpensive and widely available solutions self evident before long or simply make this danger fade away.

Leave a Reply

Your email address will not be published. Required fields are marked *